Vertaling van "applications for marketing " (Nederlands → Frans) :

TERMINOLOGIE

extracorporele applicator voor hyperthermiesysteem voor extravasculaire circulatie
applicateur extracorporel de système d’hyperthermie de circulation extravasculaire

applicator voor aneurysmaclip
applicateur de clips d’anévrisme

applicator voor compressiekousen
enfile-bas de contention

applicator voor dermale anesthesie
applicateur dermique d’anesthésie locale

handbediende applicator voor brachytherapiesysteem voor oog
applicateur manuel de système de brachythérapie oculaire

applicator voor thermisch pulsatiesysteem voor ooglid
applicateur pour système de traitement thermique par impulsions sur les paupières

intracorporele applicator voor hyperthermiesysteem voor extravasculaire circulatie
applicateur intracorporel de système d’hyperthermie de circulation extravasculaire

handbediende applicator voor oesofageaal brachytherapiesysteem
applicateur manuel de système de brachythérapie pour l’œsophage

applicator voor oesofageaal brachytherapiesysteem met op afstand bedienbare afterloading
applicateur de système de brachythérapie pour l’œsophage à chargement différé à distance

applicator voor tandheelkundige hars
applicateur de matériau de restauration dentaire

IN-CONTEXT TRANSLATIONS

applications for marketing authorisation (MA)
applications for marketing authorisation (MA)

The Registration (marketing authorisation) department of the FAMHP is responsible for evaluating new applications and applications for changes to existing marketing authorisations (variations), with a view to grant the authorisation for marketing a medicine or health product.
The Registration (marketing authorisation) department of the FAMHP is responsible for evaluating new applications and applications for changes to existing marketing authorisations (variations), with a view to grant the authorisation for marketing a medicine or health product.

The FAMHP’s Marketing authorisation Department is responsible for evaluating new applications and requests for amendments to existing marketing authorisation (MA) with a view to granting authorisation for marketing a medicine or health product.
The FAMHP’s Marketing authorisation Department is responsible for evaluating new applications and requests for amendments to existing marketing authorisation (MA) with a view to granting authorisation for marketing a medicine or health product.

The Registration (marketing authorisation) department for its part is required to evaluate applications for a marketing authorisation (MA), for the sake of the National Procedure (NP), the European Decentralised Procedure (DCP), the Mutual Recognition Procedure (MRP) and the Central Procedure (CP).
The Registration (marketing authorisation) department for its part is required to evaluate applications for a marketing authorisation (MA), for the sake of the National Procedure (NP), the European Decentralised Procedure (DCP), the Mutual Recognition Procedure (MRP) and the Central Procedure (CP).

Each application for such licences is accompanied by an extensive investigation of the legitimacy of the application and of the market participants 280 Pre export notifications (PEN) 1224 preliminary notifications of intra-Community transactions
Each application for such licences is accompanied by an extensive investigation of the legitimacy of the application and of the market participants 280 Pre export notifications (PEN) 1224 preliminary notifications of intra-Community transactions

Veterinary medicines Unit For the fifth year in a row the number of applications closed for obtaining marketing authorisation (MA) within the Veterinary medicines Unit has exceeded the number of new applications submitted.
Veterinary medicines Unit For the fifth year in a row the number of applications closed for obtaining marketing authorisation (MA) within the Veterinary medicines Unit has exceeded the number of new applications submitted.

In September, the decision was made to withdraw a separate application for EU Marketing Authorization for Rasival, the combination of aliskiren and valsartan.
En septembre, la décision a été prise de retirer une demande d’autorisation de mise sur le marché dans l’EU de Rasival, une combinaison d’aliskirène et de valsartan.

In Europa wordt er een Market Authorization Application (MAA) aangevraagd bij het Europees geneesmiddelenbureau.
En Europe, une Market Autorisation Application (MAA) est demandée à l'Agence Européenne du Médicament.

This agreement provides for an enhanced collaboration between the two institutions in the evaluation of quality data in applications for MA or associated amendments (variations) for vaccines for veterinary use, “Good Manufacturing Practices” inspection (GMP) and post-marketing reviews (monitoring by the FAMHP on samples taken).
This agreement provides for an enhanced collaboration between the two institutions in the evaluation of quality data in applications for MA or associated amendments (variations) for vaccines for veterinary use, “Good Manufacturing Practices” inspection (GMP) and post-marketing reviews (monitoring by the FAMHP on samples taken).